BioSig Technologies, Inc.
BSGM
$0.736
-$0.0016-0.22%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -72.34% | -85.45% | -90.46% | -93.71% | -11.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -72.34% | -85.45% | -90.46% | -93.71% | -11.32% |
| Cost of Revenue | -- | -- | -- | -- | -10.00% |
| Gross Profit | -65.79% | -81.65% | -88.05% | -92.14% | -11.63% |
| SG&A Expenses | -35.73% | -40.37% | -7.11% | 7.94% | 4.32% |
| Depreciation & Amortization | -28.49% | -9.04% | 10.25% | 23.21% | 31.95% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -40.20% | -41.55% | -9.42% | 3.55% | 0.20% |
| Operating Income | 40.04% | 41.17% | 8.56% | -4.57% | -0.26% |
| Income Before Tax | 48.01% | 45.29% | 6.98% | -5.24% | -1.00% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 48.01% | 45.29% | 6.98% | -5.24% | -1.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 122.45% | -280.25% | -345.57% | -267.14% | -174.38% |
| Net Income | 48.98% | 43.53% | 4.96% | -7.35% | -4.22% |
| EBIT | 40.04% | 41.17% | 8.56% | -4.57% | -0.26% |
| EBITDA | 40.18% | 41.52% | 8.79% | -4.37% | 0.03% |
| EPS Basic | 68.82% | 64.63% | 40.55% | 37.22% | 37.18% |
| Normalized Basic EPS | 66.30% | 62.45% | 39.97% | 36.02% | 36.03% |
| EPS Diluted | 68.82% | 64.63% | 40.55% | 37.22% | 37.18% |
| Normalized Diluted EPS | 66.30% | 62.45% | 39.97% | 36.02% | 36.03% |
| Average Basic Shares Outstanding | 84.09% | 70.64% | 67.15% | 70.95% | 65.69% |
| Average Diluted Shares Outstanding | 84.09% | 70.64% | 67.15% | 70.95% | 65.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
